{
  "id": "12fb2c720bdb78bf",
  "title": "STAT+: Pfizer moves forward with its hopes for a monthly obesity drug",
  "description": "Pfizer reported that its newly acquired weight loss drug showed promise as a monthly treatment, though the field is growing increasingly competitive.",
  "content": "Pfizer reported that its newly acquired weight loss drug showed promise as a monthly treatment, though the field is growing increasingly competitive.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/03/pfizer-obesity-weight-loss-drug-monthly-metsera-pf3944-met097/?utm_campaign=rss",
  "published_at": "2026-02-03T12:22:33+00:00",
  "fetched_at": "2026-02-04T00:26:40.270602+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pfizer moves forward with its hopes for a monthly obesity drug",
    "description": "Pfizer reported that its newly acquired weight loss drug showed promise as a monthly treatment, though the field is growing increasingly competitive.",
    "url": "https://www.statnews.com/2026/02/03/pfizer-obesity-weight-loss-drug-monthly-metsera-pf3944-met097/?utm_campaign=rss",
    "published": "2026-02-03T12:22:33+00:00",
    "source": "STAT"
  }
}